81136-48-3

Basic information

• Product Name: 4-(3-methoxyphenyl)amino-5,6-tetramethylenothieno<2,3-d>pyrimidine
• Synonyms: 4-(3-methoxyphenyl)amino-5,6-tetramethylenothieno<2,3-d>pyrimidine
• CAS NO: 81136-48-3
• Molecular Weight: 311.407
• Mol File: 81136-48-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(3-methoxyphenyl)amino-5,6-tetramethylenothieno<2,3-d>pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-methoxyphenyl)amino-5,6-tetramethylenothieno<2,3-d>pyrimidine(81136-48-3)
• EPA Substance Registry System: 4-(3-methoxyphenyl)amino-5,6-tetramethylenothieno<2,3-d>pyrimidine(81136-48-3)

Safety Data

• Hazardous Substances Data: 81136-48-3(Hazardous Substances Data)

Upstream product

• 536-90-3 m-Anisidine 
• 4651-91-6 3-cyano-2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene 
• 4506-71-2 ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 
• 108-94-1 cyclohexanone 
• 14346-24-8 5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyrimidin-4-one 
• 40493-18-3 4-chloro-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine 

Relevant articles and documents

Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma

MAP Kinase Interacting Serine/Threonine Kinase 1 (MNK1)play important roles in the signaling transduction of MAPK pathways. It is significantly overexpressed in renal clear cell carcinoma and head-neck squamous cell carcinoma tissues in both mRNA and prot

THERAPEUTIC APPLICATION OF TRICICLIC AROMATIC AND SATURATED BENZO(4,5)THIENO-(2,3-D)PYRIMIDINE DERIVATES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS

The subject of the invention is therapeutic application of tricyclic aromatic and saturated benzo[4,5]thieno[2,3-d]pyrimidine derivatives and their therapeutically acceptable salts. The compounds according to the invention is used particularly as active agent of therapeutic preparations of tyrosine-kinase inhibiting action.